argenx SE reported $8.42B in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
AstraZeneca USD 50.3B 2.96B Jun/2026
Genmab DKK 5.96B 275M Jun/2026
GlaxoSmithKline GBP 17.64B 223M Jun/2026
GRIFOLS EUR 7.98B 2.52B Jun/2026
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Lakefront Biotherapeutics EUR 3.26B 10.26M Jun/2026
Qiagen NV USD 3.36B 26.03M Jun/2026
UCB EUR 10.87B 1.18B Dec/2025